Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

Authors: Aviram M.¹; Rosenblat M.; Bisgaier C.L.; Newton R.S.

Source: Atherosclerosis, Volume 138, Number 2, June 1998 , pp. 271-280(10)

Publisher: Elsevier

Keywords: Lipid peroxidation; LDL; VLDL; HDL; Atorvastatin; Gemfibrozil; Paraoxonase

Language: English

Document Type: Research article

DOI: 10.1016/S0021-9150(98)00032-X

Affiliations: 1: The Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel

Links for this article

http://www.ingentaconnect.com/els/00219150/1998/00000138/00000002/art00032
http://openurl.ingenta.com/content?genre=article&issn=0021-9150&volume=138&issue=2&spage=271&epage=280
http://dx.doi.org/10.1016/S0021-9150(98)00032-X